Navigation Links
Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting

NEW ORLEANS, La., May 2 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM), a leading aesthetic medical device company, will be a first time exhibitor at The Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG) at booth #2609. The presence of Thermage at this meeting illustrates how the practice of aesthetics is becoming a more common option among Obstetricians and Gynecologists.


Research has shown that 29% of Gynecologists are performing some form of non-surgical aesthetic treatments in their office. More specifically, 15% offer at least one procedure for skin tightening, rejuvenation, contouring and/or cellulite treatment as their aesthetic component.(1)

"Incorporating aesthetic medicine into an OB/GYN office allows utilization of the existing facility and patient base for the initial launch. This gives patients the opportunity to see a doctor they know and trust. Consequently, the gynecologist capitalizes on this established credibility by simply extending the scope of service offered to many easily mastered aesthetic procedures," commented Dr Scott Kramer, an OB/GYN whose successful integration of aesthetics resulted in the opening of a medical spa to supplement his OB/GYN practice.

Thermage is attractive to many patients because it produces the subtle results over time for a younger looking appearance without surgery or injections and little to no downtime.

"A growing number of consumers continue to seek anti-aging solutions and one of the most noticeable signs of aging is lax skin," said Sherree Lucas, Vice President of Marketing of Thermage. "Thermage is considered the gold standard in skin tightening with no surgery, injections or downtime."

Thermage provides a full suite of products that can be used to help smooth, tighten and contour skin all over the body: face, eyelids, abdomen, legs and more. Thermage has recently announced several new products for Body Shaping and for the treatment of Cellulite.

To learn more about Thermage, please visit Booth #2609 or go to

About Thermage

Thermage's innovative technologies provide unique non-invasive procedures designed to smooth, tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti-aging" market. For more information about Thermage, call 1-510-259-7117 or log on to

(1) Thermage 2007 Market Research

This press release may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Thermage's business are detailed in the Company's Form 10-K for the period ended December 31, 2007. Undue reliance should not be placed on forward-looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

All our claims are based upon our FDA clearance for the non-invasive treatment of wrinkles and rhytids, including the upper and lower eyelids, and for the temporary improvement in the appearance of cellulite. Side effects are generally mild and may include redness, swelling, blisters, bumps and rare instances of surface irregularities.

SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage, Inc. to Present at the Maxim Group Growth Conference
2. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
3. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
4. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
5. Thermage, Inc. Announces Initial Shipments of Cellulite Product
6. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
7. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
8. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
9. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
10. Leading-edge body sensor could help produce sporting champions
11. Hospital Quality Info on Web Can Be Misleading
Post Your Comments:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: